Tranexamic Acid and Blood Clots in Knee Surgery

• Status: Completed
• Trial end date: 2017-11-08
• Target enrollment: 0
• Participant gender: All

Summary

This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of New Mexico
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Adult patients scheduled for total knee arthroplasty at Sandoval Regional Medical Center with an intraoperative dose of tranexamic acid

Exclusion Criteria:

• Previous deep vein thrombosis or pulmonary embolism episode

• Known coronary artery disease or peripheral vascular disease

• Previously diagnosed hypercoagulable states (e.g. Leiden factor V, antiphospholipid antibody, protein C or S deficiency)

• Pregnancy

• Creatinine clearance less than 30 ml/min

• Non-fluency in English